Quantum Computing Stock Faces Sharp Reversal After Analyst Downgrade

The quantum computing sector experienced significant turbulence as Rigetti shares underwent a dramatic reversal following an unexpected analyst rating change. After climbing an impressive 190% since the beginning of the year, the stock’s upward trajectory came to an abrupt halt when market researchers issued a sobering reassessment of its valuation.

Market Reaction to Rating Adjustment

Investment firm B. Riley Securities triggered the sell-off by downgrading Rigetti from “Buy” to “Neutral,” indicating they no longer recommend purchasing the stock at current price levels. The market response was immediate and severe, with shares plunging more than 11% and snapping a three-day winning streak. Trading activity surged dramatically, reaching $2.39 billion in volume and securing the company’s position as the 32nd most actively traded security for the session.

Valuation Concerns Emerge

In a seemingly contradictory move, B. Riley analysts simultaneously raised their price target from $35 to $42 per share. However, the stock’s market price had already surpassed this revised target, suggesting experts believe the company’s growth potential is already fully reflected in its current valuation.

Should investors sell immediately? Or is it worth buying Rigetti?

Several factors underpin these valuation concerns:

• The company’s $14.3 billion market capitalization already accounts for a substantial portion of the total market projected for 2030-2035
• Potential delays in U.S. government contracts could jeopardize future revenue streams
• With a price-to-book ratio of 25.94, Rigetti ranks among the most expensive stocks in its sector

Operational Strength Amid Market Skepticism

Despite the downgrade, Rigetti’s underlying business operations demonstrate resilience. The company maintains quarterly cash burn of approximately $19 million, which remains well-covered by liquid assets totaling $572 million. Additionally, the quantum computing specialist recently secured a $5.8 million contract from the U.S. Air Force Research Laboratory, providing near-term revenue validation.

Investors await the next critical test of the company’s valuation thesis when Rigetti reports third-quarter results on November 10. These financial figures will likely determine whether the current premium valuation remains justified or if further market adjustments lie ahead.